Evidence map›Paper›PMID 42773179›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2026

Kappa opioid receptor-dependent depressive-like behaviors associated with morphine withdrawal contribute to stress-induced reinstatement of morphine seeking.

An-An Liu, Pan-Wen Liu, Jia-Wen Luo, Song-Yu Yao, Bi-Ying Wang, Chen-Yao Wang, Ru-Feng Ye, Gui-Ying Zan, Meng Sun, Jing-Gen Liu and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

An-An Liu *Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, China.
Pan-Wen Liu *Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, China.
Jia-Wen LuoShandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, China.
Song-Yu YaoShandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, China.
Bi-Ying WangShandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, China.
Chen-Yao WangShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Ru-Feng YeDepartment of Neurobiology and Acupuncture Research, Key Laboratory of Acupuncture and Neurology of Zhejiang Province, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
Gui-Ying ZanShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Meng SunShandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, China.
Jing-Gen LiuShandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, China. jgliu@simm.ac.cn.
Yu-Jun WangShandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, China. yjwang@simm.ac.cn.ORCID http://orcid.org/0000-0002-1206-5325

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82030112; 82571743Science and Technology Commission of Shanghai Municipality (Shanghai Municipal Science and Technology Commission) 23ZR1474900Taishan Scholar Foundation of Shandong Province tsqn202312301
6 · The paper itself

Abstract

Negative effects during withdrawal heighten vulnerability to relapse in clinical settings. However, preclinical evidence linking withdrawal-induced negative emotions to relapse vulnerability remains limited. Previously, we have demonstrated that kappa opioid receptor (KORs) activation in the amygdala and subsequent inhibition of the amygdala-to-nucleus accumbens circuit mediate morphine withdrawal-induced depressive-like behaviors. In this study, we established a positive correlation between withdrawal-induced depressive-like behavior and stress-induced reinstatement in male mice. We found that morphine-treated mice displaying higher conditioned place preference (CPP) scores also exhibited more severe depressive-like behaviors during withdrawal and subsequently showed more pronounced CPP reinstatement following forced swim stress (FSS). We further found that inhibition of KOR activation in the basolateral amygdala (BLA), or activation of the BLA-NAc circuit, attenuated withdrawal-induced depressive-like behaviors and prevented subsequent stress-induced CPP reinstatement. Conversely, overexpression of KORs in the BLA-NAc circuit exacerbated these phenotypes, while genetic ablation of KORs in this circuit provided protective effects against these behaviors. Moreover, we identified a specific population of prelimbic cortex prodynorphinergic (PrL

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.